首页> 美国卫生研究院文献>Journal of Global Oncology >Primary Febrile Neutropenia Prophylaxis for Patients Who ReceiveFEC-D Chemotherapy for Breast Cancer: A Systematic Review

【2h】

Primary Febrile Neutropenia Prophylaxis for Patients Who ReceiveFEC-D Chemotherapy for Breast Cancer: A Systematic Review

机译：接受患者的原发性发热性中性粒细胞减少症的预防FEC-D乳腺癌化学疗法：系统评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeDespite widespread use of fluorouracil, epirubicin, cyclophosphamide, docetaxel (FEC-D) chemotherapy in breast cancer, the optimal strategy for primary febrile neutropenia (FN) prophylaxis remains unknown. A systematic review was therefore performed.

机译：目的尽管在乳腺癌中广泛使用氟尿嘧啶，表柔比星，环磷酰胺，多西他赛（FEC-D）化疗，但预防原发性中性粒细胞减少症（FN）的最佳策略仍然未知。因此进行了系统的审查。

著录项

期刊名称 Journal of Global Oncology
作者
Ricardo Fernandes; Sasha Mazzarello; Carol Stober; Mohamed F.K. Ibrahim; Shaan Dudani; Kirstin Perdrizet; Habeeb Majeed; Lisa Vandermeer; Risa Shorr; Brian Hutton; Dean Fergusson; Bishal Gyawali; Mark Clemons;
展开▼
作者单位

展开▼
年(卷),期 2018(4),-1
年度 2018
页码 008540
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review [J] . Fernandes Ricardo, Mazzarello Sasha, Stober Carol, Breast cancer research and treatment. . 2017,第1期

机译：最佳的主要发育中性粒细胞缺乏患者接受多西紫杉醇 - 环磷酰胺化疗乳腺癌的预防：系统评价
2. Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review [J] . Younis T., Rayson D., Jovanovic S., Breast cancer research and treatment. . 2016,第3期

机译：预防性和辅助性G-CSF预防发热性中性粒细胞减少症在乳腺癌辅助化疗中的成本效益：系统评价
3. Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. [J] . Kuderer NM, Dale DC, Crawford J, Journal of Clinical Oncology . 2007,第21期

机译：接受粒细胞集落刺激因子的一级预防对成年癌症化疗患者发热性中性粒细胞减少和死亡率的影响：系统评价。
4. Is Primary Chemotherapy Useful for AiS Patients with Primary Invasive Breast Cancer [C] . S.M. Scholl, P. Beuzeboc, A.L. Harris, International Conference on "Adjuvant Therapy of Primary Breast Cancer" . 1998

机译：是主要的化疗，可用于AIS患有原发性侵袭性乳腺癌的患者
5. Effects of primary prophylaxis of neutropenia on outcomes, utilization and expenditures for elderly breast cancer patients receiving chemotherapy. [D] . Rajan, Suja S. 2009

机译：一级预防中性粒细胞减少对老年接受化疗的乳腺癌患者的结局，利用和支出的影响。
6. Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy [O] . Jihyoun Lee, Jong Eun Lee, Zisun Kim, 2018

机译：Pegfilgrastim预防TAC化疗的乳腺癌患者发热性中性粒细胞减少
7. Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review [O] . Younis, T., Rayson, D., Jovanovic, S., 2016

机译：预防性和辅助性G-CSF预防发热性中性粒细胞减少症在乳腺癌辅助化疗中的成本效益：系统评价
8. Psychological Stress, Neutropenia and Infectious Disease in Patients Receiving Chemotherapy Treatment for Breast Cancer [R] . Bovbjerg, D. 1999

机译：乳腺癌化疗治疗患者的心理应激，中性粒细胞减少和传染病

Primary Febrile Neutropenia Prophylaxis for Patients Who ReceiveFEC-D Chemotherapy for Breast Cancer: A Systematic Review

摘要

著录项

相似文献

相关主题

期刊订阅